A retrospective study on outcome of microscopic polyangiitis in chronic renal replacement therapy

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1360-1366

  Merino, Jose Luis ^b   Galeano, Cristina ^a   Espejo, Beatriz ^b   Rivera, Maite ^a   Fernández Lucas, Milagros ^a   Calds, Silvia ^a   Plana, M Nieves ^a   Letosa, Marcn ^a   Teruel, Jose Luis ^a   Quereda, Carlos ^a   Ortuo, Joaquin ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Universidad Francisco de Vitoria   (Spain)

Author keywords

dialysis; pauci immune vasculitis; pulmonary renal syndrome; relapses

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; STEROID;

ANCA ASSOCIATED VASCULITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; FEMALE; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LEUKOPENIA; MALE; MICROSCOPIC POLYANGIITIS; MORTALITY; NECROTIZING EXTRACAPILLARY GLOMERULONEPHRITIS; OUTCOME ASSESSMENT; PAUCI IMMUNE VASCULITIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROGNOSIS; PULMONARY RENAL SYNDROME; RELAPSE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 79953846580     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq523     Document Type: Article

References (41)

1. Jeanette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003; 63: 1164-1177
2. Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 2004; 117: 39-50 (Pubitemid 38798019)
3. Chen M, Yu F, Wang SX et al. Antineutrophil cytoplasmic autoanti-body-negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol 2007; 18: 599-605 (Pubitemid 46193325)
4. Hauer HA, Bajema IM, Van Houwelingen HC et al. European Vas-culitis Study Group (EUVAS). Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 2002; 62: 1732-1742 (Pubitemid 35286281)
5. Weidanz F, Day CJ, Hewins P et al. Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis. Am J Kidney Dis 2007; 50: 36-46 (Pubitemid 46962856)
6. Allen A, Pusey C, Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 1998; 9: 1258-1263 (Pubitemid 28283889)
7. Weidner S, Geuss S, Hafezi-Rachti S et al. ANCA-associated vascu-litis with renal involvement: an outcome analysis. Nephrol Dial Transplant 2004; 19: 1403-1411 (Pubitemid 38786731)
8. Booth AD, Almond MK, Burns A et al. Pan-Thames Renal Research Group. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003; 41: 776-784 (Pubitemid 36396745)
9. Haubitz M, Koch KM, Brunkhorst R. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granuloma-tosis. Nephrol Dial Transplant 1998; 13: 1713-1718 (Pubitemid 28306800)
10. Gordon M, Luqmani RA, Adu D et al. Relapses in patients with a systemic vasculitis. Q J Med 1993; 86: 779-789 (Pubitemid 23352679)
11. Lionaki S, Hogan SL, Jennette CE et al. The clinical course of ANCA small-vessel vasculitis on chronic dialysis. Kidney Int 2009; 76: 644-651
12. Pallan L, Savage CO, Harper L. ANCA-associated vasculitis: from bench research to novel treatments. Nat Rev Nephrol 2009; 5: 278-286
13. Altieri P, Sau G, Cao R et al. Immunosuppressive treatment in dialysis patients. Nephrol Dial Transplant 2002; 17: 2-9 (Pubitemid 34918872)
14. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192 (Pubitemid 24065492)
15. Savage CO. ANCA-associated renal vasculitis. Kidney Int 2001; 60: 1614-1627 (Pubitemid 32960064)
16. Boyce NW, Holdsworth SR. Pulmonary manifestations of the clinical syndrome of acute glomerulonephritis and lung hemorrhage. Am J Kidney Dis 1986; 8: 31-36 (Pubitemid 16009433)
17. Gallagher H, Kwan JT, Jayne DR. Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 2002; 39: 42-47 (Pubitemid 34062494)
18. Nachman PH, Hogan SL, Jennette JC et al. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7: 33-39 (Pubitemid 26067089)
19. Moroni G, Torri A, Gallelli B et al. The long-term prognosis of renal transplant in patients with systemic vasculitis. Am J Transplant 2007; 7: 2133-2139 (Pubitemid 47247051)
20. Rostaing L,Modesto A, Oksman Fetal. Outcomeofpatients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis following cadaveric kidney transplantation. Am J Kidney Dis 1997; 29: 96-102 (Pubitemid 27020802)
21. Ballarin J, Díaz M. Management of immune suppression in systemic diseases affecting the kidney. Nefrologia 2008; 28: 91-96
22. Flossmann O, Harper L, Heij C et al. The European Vasculitis Study Group Vasculitis. Outcome of ANCA associated vasculitis- long-term follow up of four randomised controlled trials. ASN2007 [SU-PO1055]
23. Jayne D, Rasmussen N, Andrassy K et al. European Vasculitis Study Group. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003; 349: 36-44 (Pubitemid 36765101)
24. Westman KW, Bygren PG, Olsson H et al. Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 1998; 9: 842-852 (Pubitemid 28209094)
25. Nachman PH. Vasculitis syndromes: which maintenance therapy for ANCA vasculitis? Nat Rev Nephrol 2009; 5: 254-256
26. Pagnoux C, Mahr A, Hamidou MA et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. NEnglJ Med 2008; 359: 2790-2803
27. Descamps-Latscha B, Jungers P, Witko-Sarsat V Immune system dysregulation in uremia: role of oxidative stress. Blood Purif2002; 20: 481-484 (Pubitemid 35007567)
28. Bosch X, Mirapeix E. Vasculitis syndromes: LAMP-2 illuminates pathogenesis of ANCA glomerulonephritis. Nat Rev Nephrol 2009; 5: 247-249
29. Gera M, Griffin MD, Specks U et al. Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immu-nosupression. Kidney Int 2007; 71: 1296-1301 (Pubitemid 46884256)
30. Geetha D, Seo P. Renal transplantation in the ANCA-associated vas-culitides. Am J Transplant 2007; 7: 2657-2662
31. Chadban S. Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol 2001; 12: 394-402 (Pubitemid 32116384)
32. Nachman PH, Segelmark M, Westman K et al. Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis. Kidney Int 1999; 56: 1544-1550 (Pubitemid 29451261)
33. Elmedhem A, Adu D, Savage CO. Relapse rate and outcome of ANCA-associated small vessel vasculitis after transplantation. Nephrol Dial Transplant 2003; 18: 1001-1004 (Pubitemid 36592546)
34. Vizjak A, Rott T, Koselj-Kajtna M et al. Histologic and immunohis-tologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis 2003; 41: 539-549 (Pubitemid 36278370)
35. Franssen CF, Gans RO, Arends B et al. Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease. Kidney Int 1995; 47: 193-199
36. Gaskin G, Savage CO, Ryan JJ et al. Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 1991; 6: 689-694
37. Tervaert JW, Huitema MG, Hené RJ et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990; 336: 709-711 (Pubitemid 20309129)
38. Weidemann S, Andrassy K, Ritz E. ANCA in haemodialysis patients. Nephrol Dial Transplant 1993; 8: 839-845 (Pubitemid 23286994)
39. Niles JL, Böttinger EP, Saurina GR et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996; 156: 440-445
40. Hogan SL, Nachman PH, Wilkman AS et al. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7: 23-32 (Pubitemid 26067088)
41. Stangou M, Asimaki A, Bamichas G et al. Factors influencing patient survival and renal function outcome in pulmonary-renal syndrome associated with ANCA (+) vasculitis: a single-center experience. J Nephrol 2005; 18: 35-44 (Pubitemid 40723751)